You can read Premium News stories in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
4 October 2019
Nestlé has completed the sale of its Skin Health business for CHF10.2 billion (USD10.2 billion) to a consortium led by private-equity firm EQT and the Abu Dhabi Investment Authority (ADIA).
26 September 2019
Nestlé Health Science has taken a stake in Before Brands, Nature's Sunshine Products is entering the cannabidiol (CBD) market in the US, and Venture Life has released financial results.
24 September 2019
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has given the go-ahead for two medicines containing benzoyl peroxide – Galderma's Acnecide Face Gel and Acnecide Face Wash – to be switched from pharmacy (P) to general-sale list (GSL) status.
26 August 2019
Nestlé Health Science is expanding into personalised nutrition by acquiring the vitamins, minerals and supplements (VMS) company Persona for an undisclosed sum.
29 July 2019
Nestlé highlighted "strong demand" for its recently-launched range of Dr. Formulated CBD products when it reported financial results for the first half of 2019.
10 May 2019
Galderma is seeking to switch two medicines containing benzoyl peroxide – Acnecide Face Gel and Acnecide Face Wash – from pharmacy (P) to general-sale list (GSL) status in the UK.
24 April 2019
Nestlé expects to complete the strategic review of its Skin Health business in "mid-2019".
9 April 2019
Nestlé Health Science has announced a partnership with Amazentis, Novartis has spun off Alcon, and Daiichi-Sankyo has changed its chief executive officer.
18 February 2019
The strategic review of Nestlé Skin Health has attracted "very strong interest", with people lining up to be part of the process, according to Nestlé's chief executive officer Mark Schneider.
25 January 2019
Nestlé Skin Health has opened an office in Malaysia, as media reports suggest a number of private-equity firms are interested in making a bid for the business.